Applied Radiology is pleased to present a series of modules featuring thought-provoking dialogue between clinical experts on various topics related to the use of neuroimaging to diagnose and manage Alzheimer's Disease.
In this first module, Dr. Suzie Bash discusses the role of MRI in detecting amyloid-related imaging abnormalities with with Dr. Mike Wattjes and Dr. Achim Gass.
The Role of MRI in Detecting Amyloid-related Imaging Abnormalities (ARIA)A short written summary of the roundtable discussion.
Imaging Protocols & ARIA in Clinical PracticeDr. Suzie Bash moderates an expert panel on what protocols to use when managing ARIA.
Imaging Impact on ARIADr. Suzie Bash moderates an expert panel on the impact of imaging on ARIA.
Non-Treatment Related Imaging Abnormalities & Beta-AmyloidDr. Suzie Bash moderates an expert panel on non-treatment related issues.
Clinical Manifestations & Occurrences of ARIADr. Suzie Bash moderates an expert panel on issues related to ARIA.
Risk Factors of Developing ARIADr. Suzie Bash moderates an expert panel on the varying risk factors related to ARIA.
What is Amyloid-Related Imaging AbnormalitiesDr. Suzie Bash moderates an expert panel on what ARIA's are and how they present in clinical practice.
Anti-Amyloid TherapyDr. Suzie Bash moderates an expert panel on topics related to ARIA.
Introduction to the Role of MRI in Detecting ARIADr. Suzie Bash moderates an expert panel on the role of MRI in detecting amyloid-related imaging abnormalities.
In this second module, Dr. Suzie Bash leads a discussion with an expert panel on the latest developments of automated quantitative assessment and advanced neuroimaging techniques for a better understanding of Alzheimer’s Disease.
Future Directions of Neuroimaging in the Management of DementiaA short written summary of the roundtable discussion.
Case Study ReviewsExperts in the field of neuroimaging who diagnose and manage patients with dementia share interesting case studies.
Quantitative Volumetrics & The FutureDr. Suzie Bash moderates an expert panel who discuss the future of quantitative volumetrics in imaging.
Evolution of Neuroimaging for DementiaDr. Suzie Bash moderates an expert panel on the evolution of neuroimaging in the diagnosis and management of patients with dementia.
PET/CT Imaging in DementiaDr. Suzie Bash moderates an expert panel on the use of PET/CT for patients with dementia.
Quantitative Volumetrics: Workflow & EfficienciesDr. Suzie Bash moderates an expert panel on implementing quantitative volumetrics into your practice.
Quantitative Volumetrics: Challenges & AdoptionDr. Suzie Bash moderates an expert panel on the adopting quantitative volumetrics into clinical practice.
Quantitative Volumetrics: Radiology ReportsDr. Suzie Bash moderates an expert panel on incorporating additional information into the radiology report.
Quantitative Volumetrics: Differential Diagnosis in DementiaDr. Suzie Bash moderates an expert panel on differential diagnosis in dementia.
Quantitative Volumetrics: Benefits & ChallengesDr. Suzie Bash moderates an expert panel on the benefits and challenges related to quantitative volumetrics.
Quantitative Volumetrics in NeuroimagingDr. Suzie Bash moderates an expert panel on the role of quantitative volumetrics.
Future Directions of Neuroimaging in the Management of DementiaDr. Suzie Bash moderates and expert panel on topics related to the use of imaging in managing patients with dementia.
In this third module, Dr. Suzie Bash discusses the 2018 NIA-AA research framework based on pathologic changes related to Alzheimer’s disease with neuroradiologist, Dr. Max Wintermark and neurologist, Dr. Sharon Sha; where they explain how neuroimaging can help in the early diagnosis of Alzheimer’s Disease.
Imaging Biomarkers for the Early Diagnosis of Alzheimer’s DiseaseA short written summary of the roundtable discussion.
Case Study Review...
Aduhelm Impact on Imaging Facilities...
Neuroimaging Tools in Early Detection of Alzheimer's Disease...
NIA-AA Research Framework & the A/T/N Classification System...
Introduction to Imaging Biomarkers for Early Diagnosis of Alzheimer's Disease...
In this fourth module, Dr. Suzie Bash leads a discussion with Dr. Max Wintermark and Dr. Sharon Sha on the tips for standardizing protocols in the management of dementia in clinical practice.
The Impact of Neuroimaging in the Clinical Decision Making of Diagnosing DementiaA short written summary of the roundtable discussion.
Case Study Review...
Radiological Reports Usage...
Differentiation Between Dementia Types...
Image Protocol Standardization for Dementia...
When to Order Neuroimaging for Dementia...
© Anderson Publishing, Ltd. 2024 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.